Evidence map›Paper›PMID 27472887›Full record

ArticleCancer biomarkers : section A of Disease markers2016

hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.

Long Gong, Ying Xu, Ya-Qin Hu, Qiu-Ju Ding, Chun-Hua Yi, Wei Huang, Ming Zhou

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. TERT rs10069690 polymorphism and cancers risk: A meta-analysis.Molecular genetics & genomic medicine · 2019
    Pooled it
  4. Pooled it
  5. TERT genetic polymorphismFrontiers in surgery · 2022
    Article
  6. Article
  7. Article
  8. Associations ofInternational journal of clinical and experimental pathology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Long GongDepartment of Thyroid and Vascular Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Ying XuDepartment of Cardiology, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Ya-Qin HuDepartment of Thyroid and Vascular Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Qiu-Ju DingDepartment of Thyroid and Vascular Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Chun-Hua YiDepartment of Thyroid and Vascular Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Wei HuangDepartment of Thyroid and Vascular Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Ming ZhouDepartment of Thyroid and Vascular Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
Jingzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe study explored the association between rs10069690C/T and rs2736100G/T of human telomerase reverse transcriptase (hTERT) gene, and the prognosis of thyroid cancer.

methodsThe study had 452 thyroid cancer patients recruited as case group who hospitalized in Jingzhou Central Hospital from January 2001 to June 2004 and 452 healthy people recruited as control group at the same area. The hTERT gene polymorphisms at rs10069690 C/T and rs2736100 G/T were tested by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The association between patients' life quality and hTERT gene polymorphisms six months after surgery was evaluated based on the Cancer patients' quality of life index rating scale.

resultsThere were statistical differences in genotype and allele frequencies of rs10069690 C/T between the case group and control group (both P < 0.05). An association between rs10069690C/T polymorphism and an increased risk of thyroid cancer was shown by logistic regression analysis (CT vs. CC, OR = 1.333, 95%CI = 1.006-1.766, P = 0.045; TT vs. CC, OR = 1.910, 95%CI = 1.084-3.367, P = 0.023; CT + TT vs. CC, OR = 2.246, 95%CI = 1.078-1.840, P = 0.006; T vs. C, OR = 1.376, 95%CI = 1.104-1.715, P = 0.004). Genotype frequency of rs2736100G/T between the two groups had no statistical differences (P > 0.05). After stratification according to age, T stage, tumor size and tumor node metastasis (TNM) stage, the distribution frequencies of CC genotype and CT + TT genotype of rs10069690C/T showed significant difference (P < 0.05). The life quality of patients with CC genotype was better than that of patients with CT $+$ TT genotype. The results of Cox regression model multifactor analysis showed that age, T stage, tumor size and rs10069690C/T were independent risk factors of thyroid cancer prognosis.

conclusionshTERT gene polymorphism at rs10069690C/T is associated with the risk and prognosis of thyroid cancer, but hTERT gene polymorphism at rs2736100G/T is not.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAllelesCase-Control StudiesFemaleFollow-Up StudiesGene FrequencyGenotypeHumansMaleMiddle AgedOdds RatioPrognosisQuality of LifeRiskTelomeraseTERT protein, humangene polymorphismHuman telomerase reverse transcriptase (hTERT)life quality evaluationprognosisrs10069690C/Trs2736100G/Tthyroid cancer

Identifiers

PMID27472887
PMCPMC13020490
OpenAlexW2477629688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.